Annual EBITDA
Summary
- Current Value
- As of today, VTRS annual EBITDA is $3.22B, down -29.49% on
- Historical Performance
- VTRS annual EBITDA is down -39.93% over the past 3 years, down -9.88% over the past 5 years
- All-Time High Comparison
- VTRS annual EBITDA is currently -39.93% below its historical high of $5.36B set on
- 3-Year Low Comparison
- VTRS annual EBITDA is at its 3-year low
- Sector Comparison
- VTRS annual EBITDA is higher than 96.58% of companies in Healthcare sector
EBITDA Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $3.22B | -29.5% | -39.9% | -9.9% | +150.3% | |
| Quarterly EBITDA | $1.05B | +17.0% | -24.3% | +7.1% | +229.3% | |
| TTM EBITDA | $3.94B | -0.1% | -27.5% | +22.4% | +205.9% | |
| Price | $13.50 | +43.0% | +43.0% | -8.7% | -37.7% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $14.29B | -2.8% | -11.6% | +19.7% | +162.3% | |
| Annual EPS | -$3.00 | -464.9% | -275.9% | -169.4% | -541.5% | |
| $423.50M | -77.2% | -83.1% | -68.8% | -51.0% | ||
| Annual Net Income | -$3.51B | -454.2% | -269.1% | -424.7% | -1117.2% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $5.36B | N/A | -39.9% |
| 5Y | $5.36B | -39.9% | |
| All | $5.36B | -39.9% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $3.22B | at low | |
| 5Y | $3.22B | at low | |
| All | $2.32M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of VTRS?
As of today, VTRS annual EBITDA is $3.22B
What is 1-year change in VTRS annual EBITDA?
VTRS annual EBITDA is down -29.49% year-over-year
What is 3-year change in VTRS annual EBITDA?
VTRS annual EBITDA is down -39.93% over the past 3 years
How far is VTRS annual EBITDA from its all-time high?
VTRS annual EBITDA is currently -39.93% below its historical high of $5.36B set on December 31, 2022
How does VTRS annual EBITDA rank versus sector peers?
VTRS annual EBITDA is higher than 96.58% of companies in Healthcare sector
When is VTRS next annual earnings release?
As of today, the next annual earnings release for VTRS has not been scheduled
Quarterly EBITDA
Summary
- Current Value
- As of today, VTRS quarterly EBITDA is $1.05B, up +4.83% on
- Historical Performance
- VTRS quarterly EBITDA is up +16.97% year-over-year, down -24.28% over the past 3 years
- All-Time High Comparison
- VTRS quarterly EBITDA is currently -37.41% below its historical high of $1.68B set on
- 3-Year Low Comparison
- VTRS quarterly EBITDA is +34.19% above its 3-year low of $785.80M reached on
- Sector Comparison
- VTRS quarterly EBITDA is higher than 97.09% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.05B | +4.8% | +17.0% | -24.3% | +7.1% | |
| Annual EBITDA | $3.22B | – | -29.5% | -39.9% | -9.9% | |
| TTM EBITDA | $3.94B | +4.0% | -0.1% | -27.5% | +22.4% | |
| Price | $13.50 | +13.2% | +43.0% | +43.0% | -8.7% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $3.71B | -1.5% | +6.6% | -4.0% | +2.3% | |
| Quarterly EPS | -$0.30 | -168.0% | +31.8% | -135.6% | +72.4% | |
| -$124.20M | -139.1% | -180.0% | -123.8% | -499.4% | ||
| Quarterly Net Income | -$340.10M | -165.3% | +34.1% | -133.6% | +62.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.05B | at high | |
| 3Y | $1.39B | N/A | -24.3% |
| 5Y | $1.68B | -37.4% | |
| All | $1.68B | -37.4% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $841.70M | +25.3% | |
| 3Y | $785.80M | +34.2% | |
| 5Y | $785.80M | +34.2% | |
| All | -$56.49M | +1966.6% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of VTRS?
As of today, VTRS quarterly EBITDA is $1.05B
What is VTRS quarterly EBITDA most recent change?
VTRS quarterly EBITDA was up +4.83% on December 31, 2025
What is 1-year change in VTRS quarterly EBITDA?
VTRS quarterly EBITDA is up +16.97% year-over-year
How far is VTRS quarterly EBITDA from its all-time high?
VTRS quarterly EBITDA is currently -37.41% below its historical high of $1.68B set on June 30, 2021
How does VTRS quarterly EBITDA rank versus sector peers?
VTRS quarterly EBITDA is higher than 97.09% of companies in Healthcare sector
When is VTRS next earnings release?
The next earnings release for VTRS is on
TTM EBITDA
Summary
- Current Value
- As of today, VTRS TTM EBITDA is $3.94B, up +4.04% on
- Historical Performance
- VTRS TTM EBITDA is down -0.10% year-over-year, down -27.54% over the past 3 years
- All-Time High Comparison
- VTRS TTM EBITDA is currently -36.48% below its historical high of $6.20B set on
- 3-Year Low Comparison
- VTRS TTM EBITDA is +6.82% above its 3-year low of $3.69B reached on
- Sector Comparison
- VTRS TTM EBITDA is higher than 96.99% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $3.94B | +4.0% | -0.1% | -27.5% | +22.4% | |
| Annual EBITDA | $3.22B | – | -29.5% | -39.9% | -9.9% | |
| Quarterly EBITDA | $1.05B | +4.8% | +17.0% | -24.3% | +7.1% | |
| Price | $13.50 | +13.2% | +43.0% | +43.0% | -8.7% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $14.29B | +1.6% | -2.6% | -11.6% | +19.7% | |
| TTM EPS | -$2.96 | +4.4% | -454.9% | -273.5% | -397.6% | |
| $729.90M | -27.7% | -30.5% | -69.7% | -27.1% | ||
| TTM Net Income | -$3.51B | +4.8% | -454.2% | -269.1% | -424.7% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.94B | N/A | -0.1% |
| 3Y | $5.44B | N/A | -27.5% |
| 5Y | $6.20B | -36.5% | |
| All | $6.20B | -36.5% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.69B | +6.8% | |
| 3Y | $3.69B | +6.8% | |
| 5Y | $3.22B | N/A | +22.4% |
| All | -$56.49M | +7074.4% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of VTRS?
As of today, VTRS TTM EBITDA is $3.94B
What is VTRS TTM EBITDA most recent change?
VTRS TTM EBITDA was up +4.04% on December 31, 2025
What is 1-year change in VTRS TTM EBITDA?
VTRS TTM EBITDA is down -0.10% year-over-year
How far is VTRS TTM EBITDA from its all-time high?
VTRS TTM EBITDA is currently -36.48% below its historical high of $6.20B set on December 31, 2021
How does VTRS TTM EBITDA rank versus sector peers?
VTRS TTM EBITDA is higher than 96.99% of companies in Healthcare sector
When is VTRS next earnings release?
The next earnings release for VTRS is on
EBITDA Formula
Data Sources & References
- VTRS Official Website www.viatris.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1792044/000179204426000013/0001792044-26-000013-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1792044/000179204426000013/0001792044-26-000013-index.htm
- VTRS Profile on Yahoo Finance finance.yahoo.com/quote/VTRS
- VTRS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vtrs
